Drug

TA-8995 clinical trials

Also written Obicetrapib and TA-8995.

studies test it: 27
open now: 3
in phase 3: 6
first study started: 2008

Keep track of what changes. Save the TA-8995 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Studies by the year they started

27 studies that test it; most in 2022 (5)

Studies that test TA-8995, by start year
Year	Studies
2008	1
2009	1
2013	1
2014	3
2015	2
2021	3
2022	5
2023	3
2024	5
2025	2
2026	1

By phase

A phase 1/2 study counts in both.

Phase 1: 12
Phase 2: 10
Phase 3: 6

What it is tested for

Each study’s main condition, where its own words name it.

Dyslipidemias: 7
Hypercholesterolemia: 4
Alzheimer Disease: 2
Cardiovascular Diseases: 1
Hyperlipoproteinemia Type II: 1

Who runs them

Industry 27 · Other 0

NewAmsterdam Pharma (19) · Xention Ltd (6) · Mitsubishi Tanabe Pharma Corporation (2)

Often tested with

Tested in the same studies.

Ezetimibe (3) · Multimodality Therapy (1) · Atorvastatin (1) · Rosuvastatin (1) · Drospirenone (1) · Ethinyl Estradiol (1) · Midazolam (1) · Digoxin (1)

Studies

Open first, then newest update. How each study uses TA-8995 is read from its arms, and is right about nine times in ten.

Testing it · 27

See all 27 studies that test TA-8995 →

TA-8995 clinical trials

How studies write it

Name

Development codes

Other names

Combined with it in one product